This page shows the latest Norway news and features for those working in and with pharma, biotech and healthcare.
The decision will apply to all 27 EU member states, including Iceland, Norway and Liechtenstein.
If Valneva gets the grant from the EC, the centralised marketing authorisation would be valid in all EU member states, as well as in Iceland, Liechtenstein and Norway.
The approval applies to all 27 EU member states, as well as Iceland, Norway and Liechtenstein.
With the EC’s approval, Oxybryta has received marketing authorisation in all EU member states, as well as in Iceland, Liechtenstein and Norway.
A subsequent benefit from the EC’s approval – contingent on local reimbursement applications – is that clinicians in all EU member countries, along with Iceland, Norway and Lichtenstein, will be able to
Patients in all 27 European Union member states plus Iceland, Lichtenstein, Norway and Northern Ireland can now receive Keytruda in combination with chemotherapy.
More from news
Approximately 1 fully matching, plus 138 partially matching documents found.
Most biosimilar products are introduced into markets through tenders. We have seen discounts of 85% in Norway and 45% in France, following local negotiations.
The Coalition for Epidemic Preparedness Innovations (CEPI), an Oslo, Norway-based nonprofit, is helping to coordinate the development of a COVID-19 vaccine and is leading the efforts to finance the
Notably the biosimilar Renflexis (infliximab-abda) achieved a 70-80% price reduction to its reference product in both Norway and Denmark.
As many in the pharma industry know, the EEA allows Norway, Iceland and Liechtenstein to be part of the EMA and gain access to the new medicines at the same time.
National policy mandates to switch from the originator to biosimilars, as has been the case in Norway, have resulted in rapid and almost complete biosimilar market penetration.
More from intelligence
Approximately 0 fully matching, plus 18 partially matching documents found.
Brysting was most recently general manager of Gilead Nordics, comprising the company's businesses in Sweden, Norway, Denmark, Finland and Iceland.
Dr Wiklund joins the Oslo, Norway-based immuno-oncology specialist from Aker Biomarine Antarctic, where he served as director of product innovation.
Anna-Kirsti Aksnes and Tina Madsen join the firm. Norway's Targovax has added to its senior team with the appointment of two executives from Algeta.
The Norway-based biotech, which is focused on peptide-based vaccines for HIV, said Dr Lundemose will take over the role from March 1, when his predecessor Steen Krøyer becomes deputy
Was formerly general manager of Abbott in Norway. AbbVie, the new independent biopharma spin-out from Abbott, has appointed Matt Regan as general manager of its UK business. ... Regan was formerly general manager for Abbott in Norway and will now oversee
More from appointments
Approximately 0 fully matching, plus 5 partially matching documents found.
REACH, ENGAGE & MEASURE HCPs ONLINE - Accomplish meaningful engagement via Medthority (www.medthority.com), a trusted independent medical website. Support the...